The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis
- 9 August 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 65 (3), 448-450
- https://doi.org/10.1212/01.wnl.0000171349.06645.79
Abstract
Using protein expression profiling, the authors identified an upregulation of the chemokine B lymphocyte chemoattractant (BLC) in the CSF of patients with neuroborreliosis but not in patients with noninflammatory and various other inflammatory neurologic diseases. This upregulation was confirmed by ELISA, showing increased BLC levels in every neuroborreliosis patient while being undetectable in patients with noninflammatory neurologic diseases. These results point to BLC as a putative additional diagnostic marker for neuroborreliosis.Keywords
This publication has 8 references indexed in Scilit:
- Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokinesJournal of Immunological Methods, 2003
- The Immune Response at Onset and During Recovery From Borrelia burgdorferi MeningoradiculitisArchives of Neurology, 2003
- INCREASED EXPRESSION OF B-LYMPHOCYTE CHEMOATTRACTANT, BUT NOT PRO-INFLAMMATORY CYTOKINES, IN MUSCLE TISSUE IN RHESUS CHRONIC LYME BORRELIOSISCytokine, 2002
- Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfectionsJournal of Neuroimmunology, 2002
- Lymphoid Tissue Homing Chemokines Are Expressed in Chronic InflammationThe American Journal of Pathology, 2000
- An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosisMedical Microbiology and Immunology, 1999
- Lyme borreliosis: basic science and clinical aspectsThe Lancet, 1994
- Cerebrospinal Fluid Interleukins, Immunoglobulins, and Fibronectin in NeuroborreliosisArchives of Neurology, 1991